Liam Kelly joined Nyxoah as Chief Executive Officer in October 2026 and brings more than 25 years of leadership experience. He served as Chairman, President and Chief Executive Officer of Teleflex Incorporated (NYSE: TFX), a global provider of medical technology products, until January 2026. He led Teleflex as President and Chief Executive Officer from January 2018 and as Chairman of the Board from May 2020. Mr. Kelly joined Teleflex in 2009 and held a series of senior operating roles, including President of EMEA, President International, President Americas, and Chief Operating Officer. Before Teleflex, he spent ten years at Hill-Rom Holdings, Inc. in senior management roles. Mr. Kelly is a director of Enovis Corporation (NYSE: ENOV) and holds a Bachelor of Business Studies from the University of Limerick.
Loïc Moreau joined Nyxoah in 2022 as Chief Financial Officer and transitioned to the role of President International in 2024. He is a seasoned leader with more than 20 years of experience in Finance having held senior roles at GSK notably in M&A/Corporate Development or Country-CFO across different geographies. Prior to this, he started his career at EY (External Audit) and PwC (Corporate Finance). Loic holds a master from ESSCA Management School (France) and Master in Finance from Solvay University (Belgium).
Scott brings over 26 years of experience in the medical device industry with a proven track record in U.S. product launches, building and leading commercial organizations trademarked by strong operational execution. Scott is a passionate advocate for people and talent development. Scott graduated with the Superintendent’s Award for Excellence (Star Wreath) from the United States Military Academy at West Point, NY. After serving as a Captain in the U.S. Army, Scott received his MBA from the University of Minnesota, Carlson School of Management.
Bruno Onkelinx has 25 years of experience in highly regulated industries with the last 15 years in active implantable medical devices at Cochlear. At Cochlear he built successful teams while managing international research & development and manufacturing operations across Europe-Belgium and the US-Colorado. He led several core Cochlear products from ideation through development to commercial approval and manufacturing. During his last years at Cochlear, Bruno was leading global incubation activities supporting business development activities and external medical device start/scale-ups.
Dr. Boon joined Nyxoah after a 24 year academic and clinical career focusing on treating obstructive sleep apnea (OSA). He is dual boarded in Otolaryngology - Head and Neck Surgery and is one of the pioneers in the use of hypoglossal nerve stimulation therapy (HGNS). He is internationally recognized as one of the most experienced surgeons in performing HGNS procedures. He has lectured worldwide on OSA, has numerous publications and is co-editor of the first book on HGNS.
Jeyakumar Subbaroyan has 14 years of experience in clinical and pre-clinical neuromodulation research in the fields of urology, migraine, spinal cord injury, and various chronic pain conditions. He has successfully executed multiple clinical studies across the US, Europe and Australia managing diverse global teams. He has 4 issued patents and over 20 peer-reviewed publications. Prior to Nyxoah, Jey held various positions of increasing responsibility in medical device companies including Johnson & Johnson, Spinal Modulation Inc. (acquired by St. Jude Medical), Nevro Corp. and Onward Medical Inc. to name a few.
An Moonen joined Nyxoah in December 2020 as General Counsel, bringing over 20 years of experience. After 11 years at Linklaters (Corporate M&A), she joined cell therapy company TiGenix in 2011 where she oversaw all legal and compliance matters as General Counsel and Company Secretary. An was involved in various strategic licensing, financing and M&A transactions, including TiGenix’ Nasdaq IPO and its takeover by Takeda. An holds a law degree from the KU Leuven and a Master of Laws (LLM) degree from New York University School of Law. She is a member of the New York Bar.
Rémi Renard has more than 20 years of experience in Communication, Sales and Marketing. Throughout his career he has held multiple sales and marketing positions in medical device firms, mostly in the Cardiac Rhythm Management and OSA fields at Resmed, Boston Scientific and St. Jude Medical. Notably he successfully led sales and marketing activities related to the introduction in international markets of the first to market leadless pacemaker.
